Many cancer patients may need a sequential one-two punch of immunotherapies (IMAGE)
Caption
Anti-PD-1 cancer immunotherapies boost the body's cancer-fighting T cells, but in many patients, suppressive Tfr cells bring that progress to a grinding halt.
Credit
La Jolla Institute for Immunology
Usage Restrictions
None
License
Licensed content